Elizabeth Balcer-Kubiczek, Ph.D. Assistant Professor
Department:
Radiation Oncology
UMGCC Research Program:
Tumor Immunology and Immunotherapy
Education/Training:
College Degree:
University of Warsaw, Warsaw, Poland
Contact
Information:
Mailing Address:
University of Maryland Greenebaum Cancer Center
655 West Baltimore Street
BRB 6-009
Baltimore, MD 21201
Email:
ekubicze@umaryland.edu
Phone:
410-706-1569
Fax:
410-706-6138
Research Interests:
"beneficial and harmful effects induced in living systems by various types
of radiation at basic and translational levels"
Publications:
E.K. Balcer-Kubiczek, X.-F. Zhang, L.-H. Han, G.H. Harrison, C.C. Davis, X.-J. Zhou, V. Ioffe, W.A. McCready, J.M. Abraham and S.J. Meltzer, BIGEL analysis of gene expression in HL60 cells exposed to X-rays or magnetic fields. Radiat. Res. 150, 663-672, 1998.
E.K. Balcer-Kubiczek, X.-F. Zhang, G.H. Harrison, X.-J. Zhou, R.M. Vigneulle, R. Ove and J.-F. Xu, Delayed expression of hpS2 and prolonged expression of CIP1/WAF1/SDI1 in human tumor cells irradiated with X-rays, fission neutrons or 1 GeV/n Fe-ions. Int. J. Radiat. Biol. 75, 529-541, 1999.
E.K. Balcer-Kubiczek, G.H. Harrison, C.C. Davis, M.L. Hass and B.H. Koffman, Expression analysis of human HL60 cells exposed to 60-Hz square- or sine-wave magnetic fields. Radiat. Res. 153, 670-678, 2000.
A.S. Kennedy, G.H. Harrison, C.M. Mansfield, X.J. Zhou, J.F. Xu and E.K. Balcer-Kubiczek, Survival of colorectal cancer cell lines with Paclitaxel, radiation and 5-FU: Effect of TP53 and hMLH1 deficiency. Int. J. Oncol. (Radiat. Oncol. Invest.) 90, 175-185, 2000.
E.K. Balcer-Kubiczek, G.H. Harrison, J.F. Xu and P.L. Gutierrez, Coordinate late expression of trefoil peptide genes (pS2/TFF1 and ITF/TFF3) in human breast, colon, and gastric tumor cells exposed to X-rays. Mol. Cancer Therapeutics 1, 405-415, 2002.
Elizabeth K. Balcer-Kubiczek, Mona Attapour, Anrew S. Kennedy, and Mohan Suntharalingam, Cytotoxicity of docetaxel (Taxotere®) used as a single agent and in combination with radiation in human gastric, cervical, and pancreatic cancer cells. Submitted to Chemotherapy January 2005.
